Trial · NCT02003924
Participant flow33
How many started, completed or left each group, period by period.
1 to 20 of 33
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double-blind Phase | STARTED | Enzalutamide 160 mg | 933 | |
| Double-blind Phase | STARTED | Placebo | 468 | |
| Double-blind Phase | STARTED | Placebo Participants Crossover to Enzalutamide 160 mg | 0 | |
| Double-blind Phase | Treated | Enzalutamide 160 mg | 930 | |
| Double-blind Phase | Treated | Placebo | 465 | |
| Double-blind Phase | Treated | Placebo Participants Crossover to Enzalutamide 160 mg | 0 | |
| Double-blind Phase | COMPLETED | Enzalutamide 160 mg | 478 | |
| Double-blind Phase | COMPLETED | Placebo | 87 | |
| Double-blind Phase | COMPLETED | Placebo Participants Crossover to Enzalutamide 160 mg | 0 | |
| Double-blind Phase | NOT COMPLETED | Enzalutamide 160 mg | 455 | |
| Double-blind Phase | NOT COMPLETED | Placebo | 381 | |
| Double-blind Phase | NOT COMPLETED | Placebo Participants Crossover to Enzalutamide 160 mg | 0 | |
| Open-label Phase | STARTED | Enzalutamide 160 mg | 478 | |
| Open-label Phase | STARTED | Placebo | 0 | |
| Open-label Phase | STARTED | Placebo Participants Crossover to Enzalutamide 160 mg | 87 | |
| Open-label Phase | Treated | Enzalutamide 160 mg | 478 | |
| Open-label Phase | Treated | Placebo | 0 | |
| Open-label Phase | Treated | Placebo Participants Crossover to Enzalutamide 160 mg | 87 | |
| Open-label Phase | COMPLETED | Enzalutamide 160 mg | 378 | |
| Open-label Phase | COMPLETED | Placebo | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02003924/flow